Aurobindo Pharma sees dip in Q3 net profit; revenue, EBITDA rise

EBIDTA before Forex and Other income at Rs1,208cr, grew by 11.2% yoy; EBITDA margin for the quarter was at 20.5%.

from India Infoline News Service https://ift.tt/385RvuZ